483 Ascent Pharmaceuticals Dec 2012

483 Ascent Pharmaceuticals Dec 2012

Satheesh Thomas FDA$119.00 - Available Now

FDA investigators audited the Ascent Pharmaceuticals - Central Islip, NY, United States facility and issued 3 inspectional observations (via FDA 483) on 06 Dec 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 06 Dec 2012
  • Location: Central Islip, United States
  • FEI: 3009518416
Add To Cart